Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
HYDROGEN PEROXIDE
(2017)
Small molecule
Unknown
TOPICAL
Approved
Gingivitis; Infections; Keratosis, Seborrheic; Pharyngitis
HYDROGEN PEROXIDE
×
Maximum Phase:
4
First Approval:
2017
UNII:
BBX060AN9V
Molecule Type:
Small molecule
Molecular Formula:
H2O2
Molecular Weight:
34.01
AlogP:
0.02
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
PITAVASTATIN SODIUM
(2017)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Dyslipidemias; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II
PITAVASTATIN SODIUM
×
Maximum Phase:
4
First Approval:
2017
UNII:
29556RBN9P
Molecule Type:
Small molecule
Molecular Formula:
C25H23FNNaO4
Molecular Weight:
443.45
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DELAFLOXACIN
(2017)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
DELAFLOXACIN
×
Maximum Phase:
4
First Approval:
2017
UNII:
6315412YVF
Molecule Type:
Small molecule
Molecular Formula:
C18H12ClF3N4O4
Molecular Weight:
440.77
AlogP:
1.92
PSA:
121.68
HBD:
3.0
HBA:
#RotB:
3.0
Source:
VABORBACTAM
(2017)
Small molecule
Carbepenem-hydrolyzing beta-lactamase KPC inhibitor
Unknown
Approved
Urinary Tract Infections
VABORBACTAM
×
Maximum Phase:
4
First Approval:
2017
UNII:
1C75676F8V
Molecule Type:
Small molecule
Molecular Formula:
C12H16BNO5S
Molecular Weight:
297.14
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NIRAPARIB TOSYLATE
(2017)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
ORAL
Approved
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
NIRAPARIB TOSYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
195Q483UZD
Molecule Type:
Small molecule
Molecular Formula:
C26H30N4O5S
Molecular Weight:
510.62
AlogP:
2.59
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
NETARSUDIL DIMESYLATE
(2017)
Small molecule
Rho-associated protein kinase inhibitor
OPHTHALMIC
Approved
Glaucoma, Open-Angle; Ocular Hypertension
NETARSUDIL DIMESYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
VL756B1K0U
Molecule Type:
Small molecule
Molecular Formula:
C30H35N3O9S2
Molecular Weight:
645.76
AlogP:
4.89
PSA:
94.31
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RIBOCICLIB SUCCINATE
(2017)
Small molecule
Cyclin-dependent kinase 4 inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
RIBOCICLIB SUCCINATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
BG7HLX2919
Molecule Type:
Small molecule
Molecular Formula:
C27H36N8O5
Molecular Weight:
552.64
AlogP:
2.8
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BRIGATINIB
(2017)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
BRIGATINIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
HYW8DB273J
Molecule Type:
Small molecule
Molecular Formula:
C29H39ClN7O2P
Molecular Weight:
584.11
AlogP:
5.09
PSA:
85.86
HBD:
2.0
HBA:
#RotB:
8.0
Source:
EDARAVONE
(2017)
Small molecule
Unknown
INTRAVENOUS
Approved
Amyotrophic Lateral Sclerosis
EDARAVONE
×
Maximum Phase:
4
First Approval:
2017
UNII:
S798V6YJRP
Molecule Type:
Small molecule
Molecular Formula:
C10H10N2O
Molecular Weight:
174.2
AlogP:
1.8
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
1.0
Source:
LATANOPROSTENE BUNOD
(2017)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
LATANOPROSTENE BUNOD
×
Maximum Phase:
4
First Approval:
2017
UNII:
I6393O0922
Molecule Type:
Small molecule
Molecular Formula:
C27H41NO8
Molecular Weight:
507.62
AlogP:
3.77
PSA:
139.36
HBD:
3.0
HBA:
#RotB:
18.0
Source:
TELOTRISTAT ETIPRATE
(2017)
Small molecule
Tryptophan 5-hydroxylase inhibitor
Unknown
Approved
Diarrhea
TELOTRISTAT ETIPRATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
3T25U84H4U
Molecule Type:
Small molecule
Molecular Formula:
C36H35ClF3N7O6
Molecular Weight:
754.17
AlogP:
4.99
PSA:
131.17
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ENASIDENIB MESYLATE
(2017)
Small molecule
Isocitrate dehydrogenase [NADP], mitochondrial inhibitor
ORAL
Approved
Leukemia, Myeloid, Acute
ENASIDENIB MESYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
UF6PC17XAV
Molecule Type:
Small molecule
Molecular Formula:
C20H21F6N7O4S
Molecular Weight:
569.49
AlogP:
4.29
PSA:
108.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
COPANLISIB
(2017)
Small molecule
PI3-kinase p110-alpha subunit inhibitor
Unknown
Approved
Neoplasms
COPANLISIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
WI6V529FZ9
Molecule Type:
Small molecule
Molecular Formula:
C23H28N8O4
Molecular Weight:
480.53
AlogP:
0.66
PSA:
139.79
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NETARSUDIL
(2017)
Small molecule
Unknown
Unknown
Approved
Glaucoma
NETARSUDIL
×
Maximum Phase:
4
First Approval:
2017
UNII:
W6I5QDT7QI
Molecule Type:
Small molecule
Molecular Formula:
C28H27N3O3
Molecular Weight:
453.54
AlogP:
4.89
PSA:
94.31
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NALDEMEDINE TOSYLATE
(2017)
Small molecule
Mu opioid receptor antagonist
ORAL
Approved
Cancer Pain; Constipation
NALDEMEDINE TOSYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
V1N8F1RVVO
Molecule Type:
Small molecule
Molecular Formula:
C39H42N4O9S
Molecular Weight:
742.85
AlogP:
3.48
PSA:
141.18
HBD:
4.0
HBA:
#RotB:
6.0
Source:
RIBOCICLIB
(2017)
Small molecule
Cyclin-dependent kinase 4 inhibitor
Unknown
Approved
Unknown
RIBOCICLIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
TK8ERE8P56
Molecule Type:
Small molecule
Molecular Formula:
C23H30N8O
Molecular Weight:
434.55
AlogP:
2.8
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
5.0
Source:
COCAINE HYDROCHLORIDE
(2017)
Small molecule
Sodium channel alpha subunit blocker
NASAL
Approved
Anesthesia
COCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2017
UNII:
XH8T8T6WZH
Molecule Type:
Small molecule
Molecular Formula:
C17H22ClNO4
Molecular Weight:
339.82
AlogP:
1.87
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
3.0
Source:
NALDEMEDINE
(2017)
Small molecule
Mu opioid receptor antagonist
Unknown
Approved
Constipation
NALDEMEDINE
×
Maximum Phase:
4
First Approval:
2017
UNII:
03KSI6WLXH
Molecule Type:
Small molecule
Molecular Formula:
C32H34N4O6
Molecular Weight:
570.65
AlogP:
3.48
PSA:
141.18
HBD:
4.0
HBA:
#RotB:
6.0
Source:
PIBRENTASVIR
(2017)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C, Chronic
PIBRENTASVIR
×
Maximum Phase:
4
First Approval:
2017
UNII:
2WU922TK3L
Molecule Type:
Small molecule
Molecular Formula:
C57H65F5N10O8
Molecular Weight:
1113.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BENZNIDAZOLE
(2017)
Small molecule
Unknown
ORAL
Approved
Chagas Disease; Leishmaniasis; Trypanosomiasis
BENZNIDAZOLE
×
Maximum Phase:
4
First Approval:
2017
UNII:
YC42NRJ1ZD
Molecule Type:
Small molecule
Molecular Formula:
C12H12N4O3
Molecular Weight:
260.25
AlogP:
1.11
PSA:
90.06
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VALBENAZINE
(2017)
Small molecule
Synaptic vesicular amine transporter inhibitor
Unknown
Approved
Unknown
VALBENAZINE
×
Maximum Phase:
4
First Approval:
2017
UNII:
54K37P50KH
Molecule Type:
Small molecule
Molecular Formula:
C24H38N2O4
Molecular Weight:
418.58
AlogP:
3.56
PSA:
74.02
HBD:
1.0
HBA:
#RotB:
7.0
Source:
NIRAPARIB
(2017)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
Unknown
Approved
Neoplasms
NIRAPARIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
HMC2H89N35
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
2.59
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BICTEGRAVIR
(2018)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
Unknown
Approved
Unknown
BICTEGRAVIR
×
Maximum Phase:
4
First Approval:
2018
UNII:
8GB79LOJ07
Molecule Type:
Small molecule
Molecular Formula:
C21H18F3N3O5
Molecular Weight:
449.39
AlogP:
1.63
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AVATROMBOPAG MALEATE
(2018)
Small molecule
Thrombopoietin receptor agonist
ORAL
Approved
Liver Diseases; Thrombocytopenia
AVATROMBOPAG MALEATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
GDW7M2P1IS
Molecule Type:
Small molecule
Molecular Formula:
C33H38Cl2N6O7S2
Molecular Weight:
765.74
AlogP:
6.58
PSA:
101.9
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PRUCALOPRIDE SUCCINATE
(2018)
Small molecule
Serotonin 4 (5-HT4) receptor agonist
ORAL
Approved
Constipation
PRUCALOPRIDE SUCCINATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
4V2G75E1CK
Molecule Type:
Small molecule
Molecular Formula:
C22H32ClN3O7
Molecular Weight:
485.97
AlogP:
2.09
PSA:
76.82
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BENZHYDROCODONE
(2018)
Small molecule
Unknown
Unknown
Approved
Unknown
BENZHYDROCODONE
×
Maximum Phase:
4
First Approval:
2018
UNII:
75MS0AAZ9I
Molecule Type:
Small molecule
Molecular Formula:
C25H25NO4
Molecular Weight:
403.48
AlogP:
3.72
PSA:
48.0
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LAROTRECTINIB SULFATE
(2018)
Small molecule
Neurotrophic tyrosine kinase receptor inhibitor
ORAL
Approved
Neoplasm Metastasis; Neoplasms
LAROTRECTINIB SULFATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
RDF76R62ID
Molecule Type:
Small molecule
Molecular Formula:
C21H24F2N6O6S
Molecular Weight:
526.52
AlogP:
2.95
PSA:
86.0
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TECOVIRIMAT
(2018)
Small molecule
Envelope phospholipase F13 (p37) inhibitor
Unknown
Approved
Smallpox; Virus Diseases
TECOVIRIMAT
×
Maximum Phase:
4
First Approval:
2018
UNII:
F925RR824R
Molecule Type:
Small molecule
Molecular Formula:
C19H15F3N2O3
Molecular Weight:
376.33
AlogP:
2.4
PSA:
66.48
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BINIMETINIB
(2018)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
ORAL
Approved
Melanoma; Neoplasms
BINIMETINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
181R97MR71
Molecule Type:
Small molecule
Molecular Formula:
C17H15BrF2N4O3
Molecular Weight:
441.23
AlogP:
3.01
PSA:
88.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TALAZOPARIB TOSYLATE
(2018)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
ORAL
Approved
Breast Neoplasms
TALAZOPARIB TOSYLATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
02WK9U5NZC
Molecule Type:
Small molecule
Molecular Formula:
C26H22F2N6O4S
Molecular Weight:
552.56
AlogP:
2.63
PSA:
88.49
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ENCORAFENIB
(2018)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
ORAL
Approved
Melanoma; Neoplasms
ENCORAFENIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
8L7891MRB6
Molecule Type:
Small molecule
Molecular Formula:
C22H27ClFN7O4S
Molecular Weight:
540.02
AlogP:
3.91
PSA:
140.13
HBD:
3.0
HBA:
#RotB:
9.0
Source:
IOBENGUANE I 131
(2018)
Small molecule
Norepinephrine transporter substrate
Unknown
Approved
Neuroblastoma; Paraganglioma; Pheochromocytoma
IOBENGUANE I 131
×
Maximum Phase:
4
First Approval:
2018
UNII:
Q461L7AK4R
Molecule Type:
Small molecule
Molecular Formula:
C8H10IN3
Molecular Weight:
279.1
AlogP:
1.27
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GLASDEGIB MALEATE
(2018)
Small molecule
Smoothened homolog antagonist
ORAL
Approved
Leukemia, Myeloid, Acute
GLASDEGIB MALEATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
TH2EV99S4Z
Molecule Type:
Small molecule
Molecular Formula:
C25H26N6O5
Molecular Weight:
490.52
AlogP:
3.39
PSA:
96.84
HBD:
3.0
HBA:
#RotB:
3.0
Source:
GILTERITINIB FUMARATE
(2018)
Small molecule
Tyrosine-protein kinase receptor FLT3 inhibitor
ORAL
Approved
Leukemia, Myeloid; Leukemia, Myeloid, Acute
GILTERITINIB FUMARATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
5RZZ0Z1GJT
Molecule Type:
Small molecule
Molecular Formula:
C62H92N16O10
Molecular Weight:
1221.52
AlogP:
2.7
PSA:
121.11
HBD:
3.0
HBA:
#RotB:
9.0
Source:
FOSNETUPITANT
(2018)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSNETUPITANT
×
Maximum Phase:
4
First Approval:
2018
UNII:
T672P80L2S
Molecule Type:
Small molecule
Molecular Formula:
C31H35F6N4O5P
Molecular Weight:
688.61
AlogP:
5.74
PSA:
106.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MIGALASTAT HYDROCHLORIDE
(2018)
Small molecule
Alpha-galactosidase A stabiliser
ORAL
Approved
Fabry Disease
MIGALASTAT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
CLY7M0XD20
Molecule Type:
Small molecule
Molecular Formula:
C6H14ClNO4
Molecular Weight:
199.63
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
1
2
…
67
68
69
70
71
72
73
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA